Skip to Main Content

Paper Details

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.
Mol Cancer Ther
16
2020
CHD1L, Colorectal Cancer, Oncogenic CHD1L, TCF, Wnt, cancers, cell models, colorectal cancer, epithelial, gastrointestinal cancers, malignant colorectal cancer, mouse, oncogene, patient, patients, tumor
Author NameAffiliation
Aik Choon TanThe School of Medicine, The University of Colorado Anschutz Medical Campus
Aik Choon TanThe University of Colorado Cancer Center, The University of Colorado Anschutz Medical Campus
Aik Choon TanThe School of Medicine, The University of Colorado Anschutz Medical Campus
Aik Choon TanThe University of Colorado Cancer Center, The University of Colorado Anschutz Medical Campus
Wells A MessersmithThe School of Medicine, The University of Colorado Anschutz Medical Campus
Wells A MessersmithThe University of Colorado Cancer Center, The University of Colorado Anschutz Medical Campus
  • 1 - 6

Datasets

Release 1.2